|4Jun 8, 6:43 PM ET

Cox Russell J. 4

4 · Aeglea BioTherapeutics, Inc. · Filed Jun 8, 2018

Insider Transaction Report

Form 4
Period: 2018-06-07
Transactions
  • Award

    Director Stock Option (right to buy)

    2018-06-07+18,40018,400 total
    Exercise: $10.28Exp: 2028-06-06Common Stock (18,400 underlying)
Footnotes (1)
  • [F1]The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 7, 2018 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4